Utah Medical Products EBITDA Margin 2010-2025 | UTMD
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Utah Medical Products (UTMD) over the last 10 years. The current EBITDA margin for Utah Medical Products as of March 31, 2025 is .
| Utah Medical Products EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2025-03-31 | $0.04B | $0.02B | 41.03% |
| 2024-12-31 | $0.04B | $0.02B | 42.50% |
| 2024-09-30 | $0.04B | $0.02B | 41.86% |
| 2024-06-30 | $0.05B | $0.02B | 43.48% |
| 2024-03-31 | $0.05B | $0.02B | 44.90% |
| 2023-12-31 | $0.05B | $0.02B | 45.10% |
| 2023-09-30 | $0.05B | $0.03B | 47.17% |
| 2023-06-30 | $0.05B | $0.03B | 49.06% |
| 2023-03-31 | $0.05B | $0.03B | 50.94% |
| 2022-12-31 | $0.05B | $0.03B | 51.92% |
| 2022-09-30 | $0.05B | $0.03B | 52.94% |
| 2022-06-30 | $0.05B | $0.03B | 52.94% |
| 2022-03-31 | $0.05B | $0.03B | 52.94% |
| 2021-12-31 | $0.05B | $0.03B | 54.00% |
| 2021-09-30 | $0.05B | $0.03B | 53.06% |
| 2021-06-30 | $0.05B | $0.02B | 52.17% |
| 2021-03-31 | $0.04B | $0.02B | 50.00% |
| 2020-12-31 | $0.04B | $0.02B | 50.00% |
| 2020-09-30 | $0.04B | $0.02B | 50.00% |
| 2020-06-30 | $0.04B | $0.02B | 50.00% |
| 2020-03-31 | $0.05B | $0.02B | 51.06% |
| 2019-12-31 | $0.05B | $0.02B | 51.06% |
| 2019-09-30 | $0.05B | $0.02B | 51.11% |
| 2019-06-30 | $0.04B | $0.02B | 51.16% |
| 2019-03-31 | $0.04B | $0.02B | 52.38% |
| 2018-12-31 | $0.04B | $0.02B | 52.38% |
| 2018-09-30 | $0.04B | $0.02B | 52.38% |
| 2018-06-30 | $0.04B | $0.02B | 52.38% |
| 2018-03-31 | $0.04B | $0.02B | 52.38% |
| 2017-12-31 | $0.04B | $0.02B | 51.22% |
| 2017-09-30 | $0.04B | $0.02B | 50.00% |
| 2017-06-30 | $0.04B | $0.02B | 50.00% |
| 2017-03-31 | $0.04B | $0.02B | 48.72% |
| 2016-12-31 | $0.04B | $0.02B | 48.72% |
| 2016-09-30 | $0.04B | $0.02B | 50.00% |
| 2016-06-30 | $0.04B | $0.02B | 50.00% |
| 2016-03-31 | $0.04B | $0.02B | 50.00% |
| 2015-12-31 | $0.04B | $0.02B | 50.00% |
| 2015-09-30 | $0.04B | $0.02B | 50.00% |
| 2015-06-30 | $0.04B | $0.02B | 48.78% |
| 2015-03-31 | $0.04B | $0.02B | 48.78% |
| 2014-12-31 | $0.04B | $0.02B | 48.78% |
| 2014-09-30 | $0.04B | $0.02B | 46.34% |
| 2014-06-30 | $0.04B | $0.02B | 45.00% |
| 2014-03-31 | $0.04B | $0.02B | 45.00% |
| 2013-12-31 | $0.04B | $0.02B | 45.00% |
| 2013-09-30 | $0.04B | $0.02B | 45.00% |
| 2013-06-30 | $0.04B | $0.02B | 47.50% |
| 2013-03-31 | $0.04B | $0.02B | 45.00% |
| 2012-12-31 | $0.04B | $0.02B | 43.90% |
| 2012-09-30 | $0.04B | $0.02B | 43.90% |
| 2012-06-30 | $0.04B | $0.02B | 40.48% |
| 2012-03-31 | $0.04B | $0.02B | 40.48% |
| 2011-12-31 | $0.04B | $0.01B | 36.84% |
| 2011-09-30 | $0.03B | $0.01B | 35.29% |
| 2011-06-30 | $0.03B | $0.01B | 34.48% |
| 2011-03-31 | $0.03B | $0.01B | 32.00% |
| 2010-12-31 | $0.02B | $0.01B | 33.33% |
| 2010-09-30 | $0.02B | $0.01B | 37.50% |
| 2010-06-30 | $0.03B | $0.01B | 40.00% |
| 2010-03-31 | $0.03B | $0.01B | 40.00% |
| 2009-12-31 | $0.03B | $0.01B | 44.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.182B | $0.041B |
| Utah Medical Products is in the business of producing cost-effective devices for the healthcare industry which are predominantly proprietary, disposable and for hospital use. The company's success in rapidly producing solutions comes from its proven ability to integrate a number of engineering and technical disciplines in electronics, software, mechanical packaging, instrumentation, optics and materials. The resulting proprietary products represent significant incremental improvementsover existing clinical techniques. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $209.668B | 24.59 |
| Boston Scientific (BSX) | United States | $154.824B | 38.76 |
| Stryker (SYK) | United States | $148.439B | 31.04 |
| EssilorLuxottica (ESLOY) | France | $131.494B | 0.00 |
| Medtronic (MDT) | Ireland | $114.826B | 16.28 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.743B | 0.00 |
| Haleon (HLN) | United Kingdom | $43.081B | 24.59 |
| ResMed (RMD) | United States | $37.598B | 28.24 |
| GE HealthCare Technologies (GEHC) | United States | $34.909B | 16.57 |
| Agilent Technologies (A) | United States | $33.054B | 21.55 |
| Terumo (TRUMY) | Japan | $24.345B | 31.62 |
| Koninklijke Philips (PHG) | Netherlands | $23.697B | 16.63 |
| Insulet (PODD) | United States | $19.948B | 78.30 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.776B | 12.06 |
| Baxter (BAX) | United States | $14.312B | 10.69 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.087B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $10.417B | 0.00 |
| Demant (WILYY) | Denmark | $8.633B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.794B | 23.64 |
| Lantheus Holdings (LNTH) | United States | $5.092B | 12.85 |
| Perrigo (PRGO) | Ireland | $3.733B | 9.46 |
| Prestige Consumer Healthcare (PBH) | United States | $3.713B | 16.58 |
| Haemonetics (HAE) | United States | $3.529B | 16.07 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.347B | 27.82 |
| ICU Medical (ICUI) | United States | $3.070B | 22.64 |
| LeMaitre Vascular (LMAT) | United States | $1.855B | 41.47 |
| QuidelOrtho (QDEL) | United States | $1.804B | 12.41 |
| AtriCure (ATRC) | United States | $1.473B | 0.00 |
| Acuren (TIC) | United States | $1.444B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.242B | 12.60 |
| Green Thumb Industries (GTBIF) | United States | $1.207B | 27.14 |
| Phibro Animal Health (PAHC) | United States | $1.205B | 15.40 |
| Neogen (NEOG) | United States | $1.055B | 13.50 |
| BioLife Solutions (BLFS) | United States | $1.025B | 0.00 |
| InMode (INMD) | Israel | $0.891B | 8.98 |
| Kestra Medical Technologies (KMTS) | United States | $0.845B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.674B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.639B | 0.00 |
| Owens & Minor (OMI) | United States | $0.617B | 5.12 |
| Tilray Brands (TLRY) | Canada | $0.615B | 0.00 |
| Evolus (EOLS) | United States | $0.602B | 0.00 |
| CeriBell (CBLL) | United States | $0.565B | 0.00 |
| Valneva SE (VALN) | France | $0.553B | 0.00 |
| Surmodics (SRDX) | United States | $0.438B | 0.00 |
| SNDL (SNDL) | Canada | $0.410B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.327B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.323B | 11.89 |
| Sanuwave Health (SNWV) | United States | $0.321B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.304B | 0.00 |
| Quanterix (QTRX) | United States | $0.275B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.270B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.264B | 22.23 |
| Cerus (CERS) | United States | $0.262B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.256B | 75.83 |
| OraSure Technologies (OSUR) | United States | $0.245B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.244B | 0.00 |
| ZimVie (ZIMV) | United States | $0.241B | 10.96 |
| Biote (BTMD) | United States | $0.228B | 6.42 |
| Brainsway (BWAY) | Israel | $0.219B | 58.05 |
| Verano Holdings (VRNOF) | United States | $0.204B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.204B | 0.00 |
| Omeros (OMER) | United States | $0.204B | 0.00 |
| High Tide (HITI) | Canada | $0.203B | 0.00 |
| Organigram Global (OGI) | Canada | $0.196B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.179B | 0.00 |
| Exagen (XGN) | United States | $0.153B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.150B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.125B | 15.33 |
| TerrAscend (TSNDF) | Canada | $0.107B | 0.00 |
| Jin Medical (ZJYL) | China | $0.101B | 0.00 |
| Fonar (FONR) | United States | $0.099B | 12.74 |
| MacroGenics (MGNX) | United States | $0.097B | 0.00 |
| Veru (VERU) | United States | $0.090B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.090B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.087B | 0.00 |
| Apyx Medical (APYX) | United States | $0.086B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.081B | 0.00 |
| Zynex (ZYXI) | United States | $0.071B | 0.00 |
| Agape ATP (ATPC) | $0.071B | 0.00 | |
| InterCure (INCR) | Israel | $0.068B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.062B | 0.00 |
| ImmuCell (ICCC) | United States | $0.060B | 0.00 |
| Safety Shot (SHOT) | United States | $0.052B | 0.00 |
| United-Guardian (UG) | United States | $0.042B | 14.54 |
| Nephros (NEPH) | United States | $0.038B | 51.14 |
| Modular Medical (MODD) | United States | $0.038B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.037B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.022B | 0.00 |
| INLIF (INLF) | $0.016B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.014B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.014B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.014B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.013B | 0.00 |
| Senestech (SNES) | United States | $0.011B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| Sharps Technology (STSS) | United States | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |